23rd Jan 2012 18:03
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinary share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 23 January 2012 of an increase in the notional allocation of Ordinary share ADRs on 20 January 2012 at a price of $44.86 per ADR:-
Director/PDMR
|
Number of ADRs |
Connected Person |
Number of ADRs | ||
Dr M M Slaoui
|
19 |
Dr K Slaoui |
5 | ||
Mr W C Louv
| 8 | - | - | ||
Dr D Pulman
| 13 | - | - | ||
|
| ||||
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
23 January 2012
Related Shares:
Glaxosmithkline